Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bradley J Atkinson

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Supportive Oncology|October 19, 2011
Radiopharmaceuticals: present and futureBradley J Atkinson, Shi-Ming Tu
Medical Mycology|January 31, 2009
Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcomeBradley J Atkinson, Russell E Lewis, Dimitrios P Kontoyiannis
The Annals of Pharmacotherapy|February 10, 2011
Rhabdomyolysis in a Prostate Cancer Patient Taking Ketoconazole and Simvastatin: Case Report and Review of the LiteratureJack L Watkins, Bradley J Atkinson, Lance C Pagliaro
Pharmacotherapy|September 20, 2011
Cancer immunotherapy: sipuleucel-T and beyondAimee E Hammerstrom, Diana H Cauley, Bradley J Atkinson, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 16, 2014
Proteinuria with first-line therapy of metastatic renal cell cancerJosiah D Land, Adrienne H Chen, Bradley J Atkinson, et al.
The Journal of Urology|September 11, 2013
Clinical outcomes for patients with metastatic renal cell carcinoma treated with alternative sunitinib schedulesBradley J Atkinson, Sarathi Kalra, Xuemei Wang, et al.
Clinical Genitourinary Cancer|February 26, 2014
Outcomes of patients with metastatic renal cell carcinoma and end-stage renal disease receiving dialysis and targeted therapies: a single institution experienceAditya V Shetty, Marc R Matrana, Bradley J Atkinson, et al.
BJU International|September 24, 2013
Mammalian target of rapamycin (mTOR) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomesBradley J Atkinson, Diana H Cauley, Chaan Ng, et al.
BJU International|March 2, 2011
Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centreEric Jonasch, Lincy S Lal, Bradley J Atkinson, et al.
Clinical Genitourinary Cancer|January 1, 2017
Safety of Same-day Pegfilgrastim Administration in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel With or Without CarboplatinMehmet Asim Bilen, Diana H Cauley, Bradley J Atkinson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Supportive Oncology|October 19, 2011
Radiopharmaceuticals: present and futureBradley J Atkinson, Shi-Ming Tu
Medical Mycology|January 31, 2009
Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcomeBradley J Atkinson, Russell E Lewis, Dimitrios P Kontoyiannis
The Annals of Pharmacotherapy|February 10, 2011
Rhabdomyolysis in a Prostate Cancer Patient Taking Ketoconazole and Simvastatin: Case Report and Review of the LiteratureJack L Watkins, Bradley J Atkinson, Lance C Pagliaro
Pharmacotherapy|September 20, 2011
Cancer immunotherapy: sipuleucel-T and beyondAimee E Hammerstrom, Diana H Cauley, Bradley J Atkinson, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 16, 2014
Proteinuria with first-line therapy of metastatic renal cell cancerJosiah D Land, Adrienne H Chen, Bradley J Atkinson, et al.
The Journal of Urology|September 11, 2013
Clinical outcomes for patients with metastatic renal cell carcinoma treated with alternative sunitinib schedulesBradley J Atkinson, Sarathi Kalra, Xuemei Wang, et al.
Clinical Genitourinary Cancer|February 26, 2014
Outcomes of patients with metastatic renal cell carcinoma and end-stage renal disease receiving dialysis and targeted therapies: a single institution experienceAditya V Shetty, Marc R Matrana, Bradley J Atkinson, et al.
BJU International|September 24, 2013
Mammalian target of rapamycin (mTOR) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomesBradley J Atkinson, Diana H Cauley, Chaan Ng, et al.
BJU International|March 2, 2011
Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centreEric Jonasch, Lincy S Lal, Bradley J Atkinson, et al.
Clinical Genitourinary Cancer|January 1, 2017
Safety of Same-day Pegfilgrastim Administration in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel With or Without CarboplatinMehmet Asim Bilen, Diana H Cauley, Bradley J Atkinson, et al.
Pageof 2